Physician distress when treatments fail. Survey on physician distress when treating persons with drug-resistant epilepsy and knowledge of neuropalliative care.

Drug-resistant epilepsy Epilepsy surgery Medical provider distress Neuropalliative care Palliative care

Journal

Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858

Informations de publication

Date de publication:
03 2023
Historique:
received: 13 07 2022
revised: 02 09 2022
accepted: 18 09 2022
pubmed: 13 2 2023
medline: 11 3 2023
entrez: 12 2 2023
Statut: ppublish

Résumé

Drug-resistant epilepsy can be difficult to cure and may pose emotional challenges for epilepsy providers. Neuropalliative care (NPC) can augment quality of life (QOL) in persons with neurological diseases and may add meaningful elements to the treatment repertoire of epilepsy specialists even if seizures continue. However, NPC has not been widely implemented in epilepsy. Our study aimed to determine whether physicians of persons with drug-resistant epilepsy (PWDRE) experience distress when faced with treatment failure (Engel class ≥ 2), either failure of medications-only (PWDREmo) or of both medications and surgery (procedures with curative intent (PWDREms)). Furthermore, we evaluated physician knowledge about and referrals to NPC following treatment failures to help improve patient QOL despite ongoing seizures. An anonymous online survey was distributed to US epilepsy physicians through the American Epilepsy Society website and personal email to assess levels of distress experienced when caring for PWDREmo and PWDREms (7-point Likert scale ["1" = "no distress", "7" = "most distress ever felt"]), and knowledge and use of NPC. Eighty-two physicians completed the survey. Most experienced distress when epilepsy treatments failed: 59% felt moderate distress (≥4) with PWDREmo (median "4", mean 3.74, range 1-7), 90% suffered moderate to severe distress (5, 5.17, 1-7) with PWDREms. Distress over PWDREms was significantly greater than distress over PWDREmo (p < 0.0001). Forty-three percent reported confidence in their knowledge about NPC. Only 15% were likely to refer PWDREmo to NPC, while 44% would consider it for PWDREms. Among survey responders, physician distress was high when confronted with treatment failures, especially the failure of epilepsy surgery. Fewer than half of responders were likely to refer patients to NPC. Further research is necessary to determine extent, reasons, and effects of physician distress and whether improved understanding of and patient access to NPC would help alleviate physician distress when faced with treatment failures in PWDRE.

Identifiants

pubmed: 36774670
pii: S1525-5050(22)00374-2
doi: 10.1016/j.yebeh.2022.108925
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108925

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Cornelia Drees (C)

Department of Neurology, University of Colorado, Denver, United States(2); Department of Neurology, Mayo Clinic Arizona, Phoenix, United States(3). Electronic address: cornelia.drees@cuanschutz.edu.

Alison M Hixon (AM)

Department of Neurology, University of Colorado, Denver, United States(2); Barnes-Jewish Hospital, Washington University, St. Louis, United States(3). Electronic address: a.hixon@wustl.edu.

Stefan Sillau (S)

Department of Neurology, University of Colorado, Denver, United States(2). Electronic address: stefan.sillau@cuanschutz.edu.

Natalie Lopez-Esquibel (N)

Department of Neurology, University of Colorado, Denver, United States(2). Electronic address: natalie.lopez-esquibel@cuanschutz.edu.

Mark Spitz (M)

Department of Neurology, University of Colorado, Denver, United States(2). Electronic address: mark.spitz@cuanschutz.edu.

Ryan Mohler (R)

Department of Neurology, University of Colorado, Denver, United States(2).

Christine Baca (C)

Department of Neurology, University of Colorado, Denver, United States(2); Department of Neurology, Virginia Commonwealth University, Richmond, United States(3). Electronic address: christine.baca@vcuhealth.org.

Kirsten Fetrow (K)

Department of Neurology, University of Colorado, Denver, United States(2); Department of Pediatrics, Children's Hospital Colorado, University of Colorado, Denver, United States(3). Electronic address: kirsten.fetrow@childrenscolorado.org.

Mesha-Gay Brown (MG)

Department of Neurology, University of Colorado, Denver, United States(2); Department of Neurology, Centura Health, Denver, United States(3). Electronic address: meshagaybrown@centura.org.

Christina Vaughan (C)

Department of Neurology, University of Colorado, Denver, United States(2). Electronic address: christina.vaughan@cuanschutz.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH